Concepta PLC Sales Order (2484W)
November 13 2017 - 1:00AM
UK Regulatory
TIDMCPT
RNS Number : 2484W
Concepta PLC
13 November 2017
13 November 2017
Concepta plc
("Concepta" or the "Company")
GBP600,000 sales order confirmed
Concepta plc (AIM: CPT), the pioneering UK healthcare company
and developer of a proprietary platform and suite of products
targeted at the personalised mobile health market with a primary
focus on women's fertility and specifically unexplained
infertility, is pleased to announce that the Company has received
formal confirmation of a GBP600,000 sales order (the "Order") (RMB
5,058,196).
The order for 5,200 of Concepta's myLotus meters was previously
announced on 6 November 2017 and has been placed by ShanDong WeiHai
HaiChen Pharmaceutical Co. Ltd in China. Revenues from this order
will be realised in Q4 2017.
The order has been received from ShanDong WeiHai HaiChen
Pharmaceutical Co. Ltd based in WeiHai City, ShanDong Province and
covers the territories Beijing, Shanghai, ShanDong Province and
Henan Province.
Erik Henau, CEO of Concepta plc said: "I am very pleased to be
able to confirm the receipt of this significant order for our
myLotus product. We are now starting to see our considerable
investment in relationship building, marketing, and setting up
manufacturing, logistics and distribution begin to bear fruit in
China. We expect to be able to announce further orders in the
coming months and I look forward to updating shareholders in due
course."
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have
been deemed inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014 until the release of this
announcement.
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 1234 866601
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin / Mark Brady
Tel: +44 (0)20 368 3550
Beaufort Securities Limited (Broker)
Jon Belliss
Tel: +44 (0)20 7382 8300
Yellow Jersey (Financial PR)
Georgia Colkin / Joe Burgess / Katie Bairsto
Tel: +44 (0) 776 932 5254
About Concepta Plc:
Concepta plc is a pioneering UK healthcare company that has
developed a proprietary platform and products targeted at the
personalised mobile health market with a primary focus on women's
fertility and specifically unexplained infertility*.
Founded in 2013, Concepta has developed a revolutionary flagship
product 'MyLotus' for home self-testing that helps women with
unexplained infertility to conceive.
MyLotus is the only consumer product which allows both
quantitative and qualitative measurements of measurement of a
woman's personal hCG and LH hormone levels in an easy to use home
test to facilitate higher conception rates and early diagnosis of
any fertility problems. Competitor products currently only allow
qualitative measurement and are based on the 'average woman'.
Concepta has a defined route to market for its new 'My Lotus'
product with Regulatory approvals for launch in China in place for
2016 and CE-Marking for UK and Europe to follow in 2018 where the
revenue potential of the Chinese and EU infertility market is worth
c.GBP600m per annum for the company.
*Unexplained infertility refers to women that have been unable
to conceive after 6 months of trying. This highly motivated target
group of consumers won't typically be offered medical intervention
until 12 months of unsuccessfully trying, with IVF not offered
until two years. Research indicates couples start to take positive
action ahead of this time and there is little medical support to
help them do so.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFFAEFEFWSELF
(END) Dow Jones Newswires
November 13, 2017 02:00 ET (07:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024